Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer: NJLCG1402.
Eisaku MiyauchiHisashi TanakaAtsushi NakamuraToshiyuki HaradaTaku NakagawaMami MoritaDaisuke JinguTomoya KudaShunichi GamouRyota SaitoAkira InouePublished in: Thoracic cancer (2021)
Biweekly nab-PTX monotherapy was well tolerated and exhibited favorable antitumor activity in patients with previously treated NSCLC.